RYR2 and heart failure: Studies in a canine model of heart failure show that beta-adrenergic receptor blockers improve the structure and function of the ryanodine receptor (a cardiac calcium release channel) by reversing PKA hyperphosphorylation of RyR2, restoring the stoichiometry of the RyR2 macromolecular complex, and normalizing single-channel function [31].